Warren Buffett’s Berkshire Hathaway Has Held DaVita Inc. (DVA) Since 2011
Key takeaways
- Warren Buffett’s Berkshire Hathaway Has Held Da Vita Inc.
- (NYSE:DVA) is a healthcare company that caters to the needs of people suffering from kidney ailments.
- While we acknowledge the potential of DVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk.
Warren Buffett’s Berkshire Hathaway Has Held Da Vita Inc. (DVA) Since 2011 Ramish Cheema Wed, July 1, 2026 at 12:31 AM GMT+7 1 min read DVA BRK-B Da Vita Inc. (NYSE:DVA) is one of the 10 Best Long-Term Stocks to Buy Now According to Warren Buffett.
Da Vita Inc. (NYSE:DVA) is a healthcare company that caters to the needs of people suffering from kidney ailments. Another long-term Warren Buffet stock pick, Berkshire first disclosed a stake in the firm in the fourth quarter of 2011. Back then, the firm disclosed holding 5.3 million shares that were worth $203 million. The number of shares jumped considerably by the next quarter, when Berkshire held 12 million shares that were worth $541 million. By Q4 2014, Warren Buffett's firm had held 38.6 million shares and was stuck at this level until Q4 2019. As of the first quarter of 2026, Berkshire disclosed holding 30 million shares that were worth $4.6 billion.
Deutsche Bank discussed DaVita Inc. (NYSE:DVA)'s shares on May 6th when it bumped the rating to Buy from Hold and raised the share price target to $220 from $216. The coverage followed the firm's first quarter earnings, which saw it post $417.59 in revenue per treatment to beat analyst estimates. During the quarter, DaVita Inc. (NYSE:DVA)'s operating income was $482 million.